These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14194111)

  • 1. SURFACE FACTOR MECHANISMS IN RELATION TO BLOOD PLATELETS: EVIDENCE THAT ACTIVATED HAGEMAN FACTOR IS PRESENT ON THE SURFACE OF PLATELETS.
    IATRIDIS PG; FERGUSON JH; IATRIDIS SG
    Thromb Diath Haemorrh; 1964 Jul; 11():355-71. PubMed ID: 14194111
    [No Abstract]   [Full Text] [Related]  

  • 2. THE PLASMATIC ATMOSPHERE OF BLOOD PLATELETS. EVIDENCE THAT ONLY FIBRINOGEN, ACG, AND ACTIVATED HAGEMAN FACTOR ARE PRESENT ON THE SURFACE OF PLATELETS.
    IATRIDIS PG; FERGUSON JH
    Thromb Diath Haemorrh; 1965 Mar; 13():114-25. PubMed ID: 14285960
    [No Abstract]   [Full Text] [Related]  

  • 3. ROLES OF SURFACE FACTOR AND A PLASMA INHIBITORY ACTIVITY (ANTI-SF) DURING EXPERIMENTAL THROMBOSIS IN RABBITS.
    IATRIDIS SG; IATRIDIS PG; FERGUSON JH
    Thromb Diath Haemorrh; 1964 Dec; 12():489-504. PubMed ID: 14254706
    [No Abstract]   [Full Text] [Related]  

  • 4. The purification of activated Hageman factor (activated factor XII).
    RATNOFF OD; DAVIE EW
    Biochemistry; 1962 Nov; 1():967-75. PubMed ID: 13973274
    [No Abstract]   [Full Text] [Related]  

  • 5. THE BIOLOGICAL HALF-TIME OF HAGEMAN FACTOR.
    VELTKAMP JJ; LOELIGER EA; HEMKER HC
    Thromb Diath Haemorrh; 1965 Mar; 13():1-7. PubMed ID: 14285970
    [No Abstract]   [Full Text] [Related]  

  • 6. [DURATION OF LIFE OF THE HAGEMAN FACTOR (FACTOR XII)].
    JOSSO F; PROU-WARTELLE O; CHARLAS J
    Nouv Rev Fr Hematol; 1964; 4():454-6. PubMed ID: 14186229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmatic coagulation factors in hyperlipoproteinemias].
    Zöller H; Fromme K; Gross W
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):201-4. PubMed ID: 4360448
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytic properties of the Hageman factor. (Thromboelastographical study)].
    AZNAR J; LOPEZ BORRASCA A; CALATAYUD R; BARATA JJ
    Rev Clin Esp; 1963 Jun; 89():276-81. PubMed ID: 13965764
    [No Abstract]   [Full Text] [Related]  

  • 9. [LIVER AND BLOOD COAGULATION. I. BEHAVIOR OF FACTOR XII (HAGEMAN), OF FACTOR X (STUART) AND OF FIBRINOGEN IN LIVER PATIENTS].
    BOLANDRINA E; SOARDI F
    Gazz Int Med Chir; 1964 Jan; 68():63-79. PubMed ID: 14123792
    [No Abstract]   [Full Text] [Related]  

  • 10. The significance of the Hageman-factor for the effect of wettable surface on thrombocytes.
    JUERGENS J
    Thromb Diath Haemorrh; 1962 Mar; 7():48-69. PubMed ID: 14452719
    [No Abstract]   [Full Text] [Related]  

  • 11. [HAGEMAN FACTOR DEFICIENCY].
    VERRASTRO T; COSTA MF; JAMRA M
    Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():511-6. PubMed ID: 14119075
    [No Abstract]   [Full Text] [Related]  

  • 12. Some cardiovascular and hematological changes induced in the rat by activation of Hageman factor with ellagic acid.
    Damas J; Remacle-Volon G; Adam A
    Adv Exp Med Biol; 1989; 247A():461-5. PubMed ID: 2603812
    [No Abstract]   [Full Text] [Related]  

  • 13. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P; Post R; Sise H
    Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
    [No Abstract]   [Full Text] [Related]  

  • 14. Adsorption of Hageman factor (Factor XII) on collagen.
    Niewiarowski S; Bańkowski E; Fiedoruk T
    Experientia; 1964 Jul; 20(7):367-8. PubMed ID: 5892675
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of Hageman factor by ellagic acid and the generalized Shwartzman reaction.
    McKay DG; Müller-Berghaus G; Cruse V
    Am J Pathol; 1969 Mar; 54(3):393-420. PubMed ID: 4975375
    [No Abstract]   [Full Text] [Related]  

  • 16. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.
    Ratnoff OD; Emanuelson MM; Ziats NP
    J Clin Invest; 1987 Oct; 80(4):1180-9. PubMed ID: 3498741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
    Herold R; Straub PW
    J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood coagulation dynamics under the conditions of Hageman factor deficiency: a mathematical model.
    Obraztsov IF; Kuz'min VM; Khanin MA
    Dokl Biochem Biophys; 2002; 386():248-50. PubMed ID: 12469501
    [No Abstract]   [Full Text] [Related]  

  • 20. Contact product in experimental intravascular activation of the clotting system.
    Altman R; Rouvier J; Daldin J
    Rev Bras Pesqui Med Biol; 1973; 6(5):223-8. PubMed ID: 4774622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.